Mental health conditions can take a staggering toll on an individual physically, socially and financially. Many patients languish with partially effective or ineffective treatments, even though new options are constantly entering the market. At OM1, we are using our… Continue Reading
Correctly identifying a patient with a rare disease can be like looking for a needle in a haystack: by definition, each rare disease has fewer than 200,000 patients out of more than 300M people in the US. Continue Reading
Costas Boussios, VP of Data Science, OM1 Richard Gliklich, CEO, OM1 As artificial intelligence (AI) and Big Data are lauded for their potential uses in life sciences and healthcare, it is becoming difficult to differentiate between the myriad of terms… Continue Reading
Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Dr. Rich Gliklich, CEO of OM1, to discuss how big data analytics are changing the face of real world evidence (RWE). The mission of this Cambridge, Massachusetts digital health company… Continue Reading
